Cargando…
Comment on: Incidence and Risk of Hypertension with Ramucirumab in Cancer Patients: A Meta-Analysis of Published Studies
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449384/ https://www.ncbi.nlm.nih.gov/pubmed/25910606 http://dx.doi.org/10.1007/s40261-015-0288-4 |
| _version_ | 1782373844158251008 |
|---|---|
| author | Sashegyi, Andreas Lin, Yong Ferry, David Melemed, Allen |
| author_facet | Sashegyi, Andreas Lin, Yong Ferry, David Melemed, Allen |
| author_sort | Sashegyi, Andreas |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4449384 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-44493842015-06-04 Comment on: Incidence and Risk of Hypertension with Ramucirumab in Cancer Patients: A Meta-Analysis of Published Studies Sashegyi, Andreas Lin, Yong Ferry, David Melemed, Allen Clin Drug Investig Letter to the Editor Springer International Publishing 2015-04-25 2015 /pmc/articles/PMC4449384/ /pubmed/25910606 http://dx.doi.org/10.1007/s40261-015-0288-4 Text en © The Author(s) 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
| spellingShingle | Letter to the Editor Sashegyi, Andreas Lin, Yong Ferry, David Melemed, Allen Comment on: Incidence and Risk of Hypertension with Ramucirumab in Cancer Patients: A Meta-Analysis of Published Studies |
| title | Comment on: Incidence and Risk of Hypertension with Ramucirumab in Cancer Patients: A Meta-Analysis of Published Studies |
| title_full | Comment on: Incidence and Risk of Hypertension with Ramucirumab in Cancer Patients: A Meta-Analysis of Published Studies |
| title_fullStr | Comment on: Incidence and Risk of Hypertension with Ramucirumab in Cancer Patients: A Meta-Analysis of Published Studies |
| title_full_unstemmed | Comment on: Incidence and Risk of Hypertension with Ramucirumab in Cancer Patients: A Meta-Analysis of Published Studies |
| title_short | Comment on: Incidence and Risk of Hypertension with Ramucirumab in Cancer Patients: A Meta-Analysis of Published Studies |
| title_sort | comment on: incidence and risk of hypertension with ramucirumab in cancer patients: a meta-analysis of published studies |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449384/ https://www.ncbi.nlm.nih.gov/pubmed/25910606 http://dx.doi.org/10.1007/s40261-015-0288-4 |
| work_keys_str_mv | AT sashegyiandreas commentonincidenceandriskofhypertensionwithramucirumabincancerpatientsametaanalysisofpublishedstudies AT linyong commentonincidenceandriskofhypertensionwithramucirumabincancerpatientsametaanalysisofpublishedstudies AT ferrydavid commentonincidenceandriskofhypertensionwithramucirumabincancerpatientsametaanalysisofpublishedstudies AT melemedallen commentonincidenceandriskofhypertensionwithramucirumabincancerpatientsametaanalysisofpublishedstudies |